14-102929087-G-C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_030943.4(AMN):c.514-34G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00118 in 1,597,548 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.0044   (  4   hom.,  cov: 33) 
 Exomes 𝑓:  0.00084   (  7   hom.  ) 
Consequence
 AMN
NM_030943.4 intron
NM_030943.4 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.552  
Publications
4 publications found 
Genes affected
 AMN  (HGNC:14604):  (amnion associated transmembrane protein) The protein encoded by this gene is a type I transmembrane protein. It is thought to modulate bone morphogenetic protein (BMP) receptor function by serving as an accessory or coreceptor, and thus facilitates or hinders BMP binding. It is known that the mouse AMN gene is expressed in the extraembryonic visceral endoderm layer during gastrulation, but it is found to be mutated in amnionless mouse. The encoded protein has sequence similarity to short gastrulation (Sog) and procollagen IIA proteins in Drosophila. [provided by RefSeq, Jul 2008] 
AMN Gene-Disease associations (from GenCC):
- Imerslund-Grasbeck syndrome type 1Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
 - Imerslund-Grasbeck syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82). 
BP6
Variant 14-102929087-G-C is Benign according to our data. Variant chr14-102929087-G-C is described in ClinVar as Benign. ClinVar VariationId is 1657935.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00437 (666/152302) while in subpopulation AFR AF = 0.014 (582/41568). AF 95% confidence interval is 0.0131. There are 4 homozygotes in GnomAd4. There are 309 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. 
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| AMN | NM_030943.4  | c.514-34G>C | intron_variant | Intron 5 of 11 | ENST00000299155.10 | NP_112205.2 | ||
| AMN | NM_001425246.1  | c.352-34G>C | intron_variant | Intron 5 of 11 | NP_001412175.1 | |||
| AMN | XM_011537203.4  | c.352-34G>C | intron_variant | Intron 5 of 11 | XP_011535505.1 | 
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.00437  AC: 665AN: 152184Hom.:  4  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
665
AN: 
152184
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.00150  AC: 333AN: 222038 AF XY:  0.00116   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
333
AN: 
222038
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.000845  AC: 1221AN: 1445246Hom.:  7  Cov.: 33 AF XY:  0.000788  AC XY: 567AN XY: 719354 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
1221
AN: 
1445246
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
567
AN XY: 
719354
show subpopulations 
African (AFR) 
 AF: 
AC: 
544
AN: 
33450
American (AMR) 
 AF: 
AC: 
93
AN: 
44682
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
13
AN: 
26094
East Asian (EAS) 
 AF: 
AC: 
1
AN: 
39684
South Asian (SAS) 
 AF: 
AC: 
1
AN: 
86188
European-Finnish (FIN) 
 AF: 
AC: 
4
AN: 
37612
Middle Eastern (MID) 
 AF: 
AC: 
11
AN: 
5762
European-Non Finnish (NFE) 
 AF: 
AC: 
447
AN: 
1111578
Other (OTH) 
 AF: 
AC: 
107
AN: 
60196
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.488 
Heterozygous variant carriers
 0 
 77 
 154 
 232 
 309 
 386 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 34 
 68 
 102 
 136 
 170 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.00437  AC: 666AN: 152302Hom.:  4  Cov.: 33 AF XY:  0.00415  AC XY: 309AN XY: 74470 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
666
AN: 
152302
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
309
AN XY: 
74470
show subpopulations 
African (AFR) 
 AF: 
AC: 
582
AN: 
41568
American (AMR) 
 AF: 
AC: 
47
AN: 
15306
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5164
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4834
European-Finnish (FIN) 
 AF: 
AC: 
1
AN: 
10620
Middle Eastern (MID) 
 AF: 
AC: 
1
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
25
AN: 
68018
Other (OTH) 
 AF: 
AC: 
9
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.500 
Heterozygous variant carriers
 0 
 35 
 70 
 105 
 140 
 175 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 10 
 20 
 30 
 40 
 50 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
Imerslund-Grasbeck syndrome type 2    Benign:1 
Oct 20, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Imerslund-Grasbeck syndrome    Benign:1 
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.